SCHEMBL3229956

SCHEMBL3229956

N#Cc1ccc(CBr)cc1.[N]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.56
CYP2A6 P11509 2/20 0.56
GSK3B P49841 1/20 0.47
MAOB P27338 3/20 0.46
CYP19A1 P11511 2/20 0.45
KCNJ1 P48048 1/20 0.45
KCNH2 Q12809 1/20 0.45
ALDH1A1 P00352 2/20 0.44
CA12 O43570 1/20 0.44
CA2 P00918 1/20 0.44
CA3 P07451 1/20 0.44
CA6 P23280 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
IDO1 P14902 2/20 0.44
TSHR P16473 2/20 0.42
TRPA1 O75762 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
MAOA P21397 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL531 0.97 LOXL2 (0.58) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL5486578 0.95 LOXL2 (0.56) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL1078454 0.91 LOXL2 (0.52) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL10929655 0.85 LOXL2 (0.47) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL3264554 0.85 PARP15 (0.49) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL450762 0.85 KIF11 (0.47) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL10929666 0.85 LOXL2 (0.47) LOXL2CYP2A6GSK3BMAOBCYP19A1
SCHEMBL507651 0.82 GSK3B (0.59) LOXL2CYP2A6GSK3BALDH1A1CA2
SCHEMBL10925694 0.82 MAOB (0.68) MAOBCYP19A1MAOA
SCHEMBL9432333 0.80 MAOB (0.46) LOXL2CYP2A6GSK3BMAOBCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010010186-A1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2010-01-28 WO disclosed